Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
2.100
0.00 (0.00%)
Oct 14, 2026, 1:41 PM EDT - Market open
Xenetic Biosciences Market Cap
Xenetic Biosciences has a market cap or net worth of $4.92 million as of October 14, 2026. It is the 45,064th most valuable company in the world and the 6,058th biggest in the United States. Its market cap has decreased by 40.71% in one year.
Market Cap
4.92M
Enterprise Value
-1.55M
1-Year Change
-40.71%
Global Rank
Country Rank
#6,058 United States
Category
ChartMarket Cap Chart
Since June 30, 2016, Xenetic Biosciences's market cap has decreased from $47.70M to $4.92M, a decrease of -89.68%. That is a compound annual growth rate of -19.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 4.92M | -1.59% |
| Dec 31, 2025 | 5.00M | -19.35% |
| Dec 31, 2024 | 6.20M | 16.98% |
| Dec 29, 2023 | 5.30M | 23.26% |
| Dec 30, 2022 | 4.30M | -75.14% |
| Dec 31, 2021 | 17.30M | 35.16% |
| Dec 31, 2020 | 12.80M | 54.22% |
| Dec 31, 2019 | 8.30M | -46.10% |
| Dec 31, 2018 | 15.40M | -7.78% |
| Dec 29, 2017 | 16.70M | -53.09% |
| Dec 30, 2016 | 35.60M | -25.37% |
| Jun 30, 2016 | 47.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Creative Medical Technology Holdings | 5.41M |
| KALA BIO | 5.31M |
| Cardio Diagnostics Holdings | 5.30M |
| AIM ImmunoTech | 5.16M |
| Pulmatrix | 5.00M |
| Lexaria Bioscience | 4.73M |
| Liminatus Pharma | 4.65M |
| Lunai Bioworks | 4.64M |